Latest filing published 18 May 2026 for Egetis Therapeutics AB (publ).
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Nils Hallén: trading record in brief
Nils Hallén is a declared insider of Egetis Therapeutics AB (publ), with filings sourced from Finansinspektionen. In total, 4 filings cover trades dated from 6 May 2022 to 11 May 2026.
Purchases make up the whole of the open-market record (2 purchases). The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 1 purchase and no sales.
The latest filing, published on 18 May 2026, reports an open-market purchase in Egetis Therapeutics AB (publ). Filings reach the Finansinspektionen feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Nils Hallén
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,202 shares0AktieISIN SE0003815604FI:csv-e9e8616ad9038e8953beCanonical exit: 9 Aug 2026 (T+90)
- 27,396 shares@ SEK 3.6548.6% of flowBTA (betald tecknad aktie)ISIN SE0017770027FI:csv-54ec82faadc7d367697d
- 27,396 shares@ SEK 3.8651.4% of flowBTA (betald tecknad aktie)ISIN SE0017770027FI:csv-f6843589068a569a211c
- 91,320 shares0Teckningsrätt/UniträttISIN SE0017770019FI:csv-c540483ae7c69fbfcb70Canonical exit: 4 Aug 2022 (T+90)
4 of 4 declarations